LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 6 of total 6

Search options

  1. Article ; Online: Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol.

    Thomas, Binny / Pallivalapila, Abdulrouf / El Kassem, Wessam / Tarannum, Asma / Al Hail, Fatema / Rijims, Mohammed / Parappil, Hussain / Bayo, Arabo Ibrahim / Ahmad, Shamsa / Nazar, Zachariah / Stewart, Derek / Al Hail, Moza

    Systematic reviews

    2020  Volume 9, Issue 1, Page(s) 161

    Abstract: ... review addressing therapeutic management and safety of medicines to treat COVID-19 during pregnancy and ... management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and ... three step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including ...

    Abstract Background: Over 4.2 million confirmed cases and more than 285,000 deaths, COVID-19 pandemic continues to harm significant number of people worldwide. Several studies have reported the impact of COVID-19 in general population; however, there is scarcity of information related to pharmacological management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and immunological response during pregnancy makes it more susceptible to infections. Furthermore, during pregnancy, a woman undergoes multiple interactions with the health care system that increases her chance of getting infected; therefore, managing pregnant population presents a unique challenge.
    Research questions: This systematic review seeks to answer the following questions in relation to COVID-19: What are the different clinical characteristics presented in maternal and perinatal population? What are the different maternal and perinatal outcome measures reported? What are the distinct therapeutic interventions reported to treat COVID-19? Is it safe to use "medications" used in the treatment of COVID-19 during antenatal, perinatal, postnatal, and breastfeeding?
    Method: The search will follow a comprehensive, sequential three step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including Medline, CINAHL, and LitCovid will be searched from the inception of the disease until the completion of data collection. The quality of this search strategy will be assessed using Peer Review of Electronic Search Strategies Evidence-Based Checklist (PRESS EBC). An eligibility form will be developed for a transparent screening and inclusion/exclusion of studies. All studies will be sent to RefWorks, and abstraction will be independently performed by two researchers. Risk of bias will be assessed using Cochrane Risk of Bias tool for randomized controlled trials, Newcastle-Ottawa Quality Assessment Scale for non-randomized studies, and for case reports, Murad et al. tool will be used. Decision to conduct meta-analysis will be based on several factors including homogeneity and outcome measures reported; otherwise, a narrative synthesis will be deemed appropriate.
    Discussion: This systematic review will summarize the existing data on effect of COVID-19 on maternal and perinatal population. Furthermore, to the best of our knowledge, this is the first systematic review addressing therapeutic management and safety of medicines to treat COVID-19 during pregnancy and breastfeeding.
    Systematic review registration: This systematic review has been registered and published with Prospero ( CRD42020172773 ).
    MeSH term(s) Apgar Score ; Betacoronavirus ; Breast Feeding ; COVID-19 ; Coronavirus Infections/drug therapy ; Female ; Humans ; Infant, Newborn ; Maternal Mortality ; Pandemics ; Perinatal Mortality ; Pneumonia, Viral/drug therapy ; Postpartum Hemorrhage/epidemiology ; Pre-Eclampsia/epidemiology ; Pregnancy ; Pregnancy Complications, Infectious/drug therapy ; SARS-CoV-2 ; Sepsis/epidemiology ; Treatment Outcome ; COVID-19 Drug Treatment ; Systematic Reviews as Topic
    Keywords covid19
    Language English
    Publishing date 2020-07-18
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2662257-9
    ISSN 2046-4053 ; 2046-4053
    ISSN (online) 2046-4053
    ISSN 2046-4053
    DOI 10.1186/s13643-020-01418-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy: a systematic review protocol

    Thomas, Binny / Pallivalapila, Abdulrouf / El Kassem, Wessam / Tarannum, Asma / Al Hail, Fatema / Rijims, Mohammed / Parappil, Hussain / Bayo, Arabo Ibrahim / Ahmad, Shamsa / Nazar, Zachariah / Stewart, Derek / Al Hail, Moza

    Syst Rev

    Abstract: ... review addressing therapeutic management and safety of medicines to treat COVID-19 during pregnancy and ... management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and ... step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including ...

    Abstract BACKGROUND: Over 4.2 million confirmed cases and more than 285,000 deaths, COVID-19 pandemic continues to harm significant number of people worldwide. Several studies have reported the impact of COVID-19 in general population; however, there is scarcity of information related to pharmacological management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and immunological response during pregnancy makes it more susceptible to infections. Furthermore, during pregnancy, a woman undergoes multiple interactions with the health care system that increases her chance of getting infected; therefore, managing pregnant population presents a unique challenge. RESEARCH QUESTIONS: This systematic review seeks to answer the following questions in relation to COVID-19: What are the different clinical characteristics presented in maternal and perinatal population? What are the different maternal and perinatal outcome measures reported? What are the distinct therapeutic interventions reported to treat COVID-19? Is it safe to use "medications" used in the treatment of COVID-19 during antenatal, perinatal, postnatal, and breastfeeding? METHOD: The search will follow a comprehensive, sequential three step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including Medline, CINAHL, and LitCovid will be searched from the inception of the disease until the completion of data collection. The quality of this search strategy will be assessed using Peer Review of Electronic Search Strategies Evidence-Based Checklist (PRESS EBC). An eligibility form will be developed for a transparent screening and inclusion/exclusion of studies. All studies will be sent to RefWorks, and abstraction will be independently performed by two researchers. Risk of bias will be assessed using Cochrane Risk of Bias tool for randomized controlled trials, Newcastle-Ottawa Quality Assessment Scale for non-randomized studies, and for case reports, Murad et al. tool will be used. Decision to conduct meta-analysis will be based on several factors including homogeneity and outcome measures reported; otherwise, a narrative synthesis will be deemed appropriate. DISCUSSION: This systematic review will summarize the existing data on effect of COVID-19 on maternal and perinatal population. Furthermore, to the best of our knowledge, this is the first systematic review addressing therapeutic management and safety of medicines to treat COVID-19 during pregnancy and breastfeeding. SYSTEMATIC REVIEW REGISTRATION: This systematic review has been registered and published with Prospero ( CRD42020172773 ).
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #656809
    Database COVID19

    Kategorien

  3. Article ; Online: Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy

    Thomas, Binny / Pallivalapila, Abdulrouf / El Kassem, Wessam / Tarannum, Asma / Al Hail, Fatema / Rijims, Mohammed / Parappil, Hussain / Bayo, Arabo Ibrahim / Ahmad, Shamsa / Nazar, Zachariah / Stewart, Derek / Al Hail, Moza

    Systematic Reviews

    a systematic review protocol

    2020  Volume 9, Issue 1

    Keywords Medicine (miscellaneous) ; covid19
    Language English
    Publisher Springer Science and Business Media LLC
    Publishing country us
    Document type Article ; Online
    ZDB-ID 2662257-9
    ISSN 2046-4053
    ISSN 2046-4053
    DOI 10.1186/s13643-020-01418-2
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  4. Article ; Online: Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy

    Nazar, Zachariah / Stewart, Derek

    a systematic review protocol

    2020  

    Abstract: ... review addressing therapeutic management and safety of medicines to treat COVID-19 during pregnancy and ... management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and ... step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including ...

    Abstract Background: Over 4.2 million confirmed cases and more than 285,000 deaths, COVID-19 pandemic continues to harm significant number of people worldwide. Several studies have reported the impact of COVID-19 in general population; however, there is scarcity of information related to pharmacological management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and immunological response during pregnancy makes it more susceptible to infections. Furthermore, during pregnancy, a woman undergoes multiple interactions with the health care system that increases her chance of getting infected; therefore, managing pregnant population presents a unique challenge. Research questions: This systematic review seeks to answer the following questions in relation to COVID-19: What are the different clinical characteristics presented in maternal and perinatal population? What are the different maternal and perinatal outcome measures reported? What are the distinct therapeutic interventions reported to treat COVID-19? Is it safe to use “medications” used in the treatment of COVID-19 during antenatal, perinatal, postnatal, and breastfeeding? Method: The search will follow a comprehensive, sequential three step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including Medline, CINAHL, and LitCovid will be searched from the inception of the disease until the completion of data collection. The quality of this search strategy will be assessed using Peer Review of Electronic Search Strategies Evidence-Based Checklist (PRESS EBC). An eligibility form will be developed for a transparent screening and inclusion/exclusion of studies. All studies will be sent to RefWorks, and abstraction will be independently performed by two researchers. Risk of bias will be assessed using Cochrane Risk of Bias tool for randomized controlled trials, Newcastle–Ottawa Quality Assessment Scale for non-randomized studies, and for case reports, Murad et al. tool will be used. Decision to conduct meta-analysis will be based on several factors including homogeneity and outcome measures reported; otherwise, a narrative synthesis will be deemed appropriate. Discussion: This systematic review will summarize the existing data on effect of COVID-19 on maternal and perinatal population. Furthermore, to the best of our knowledge, this is the first systematic review addressing therapeutic management and safety of medicines to treat COVID-19 during pregnancy and breastfeeding. Systematic review registration: This systematic review has been registered and published with Prospero (CRD42020172773).
    Keywords Pregnant ; Pharmacological management ; Perinatal ; Maternal ; COVID-19 ; covid19
    Subject code 306 ; 610
    Language English
    Publishing date 2020-07-19
    Publisher BMC
    Publishing country qa
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  5. Article ; Online: Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy

    Thomas, Binny / Pallivalapila, Abdulrouf / El Kassem, Wessam / Tarannum, Asma / Al Hail, Fatema / Rijims, Mohammed / Parappil, Hussain / Bayo, Arabo Ibrahim / Ahmad, Shamsa / Nazar, Zachariah / Stewart, Derek / Al Hail, Moza

    a systematic review protocol

    2020  

    Abstract: ... COVID-19 during pregnancy and breastfeeding. This systematic review has been registered and published ... this is the first systematic review addressing therapeutic management and safety of medicines to treat ... on effect of COVID-19 on maternal and perinatal population. Furthermore, to the best of our knowledge ...

    Abstract Over 4.2 million confirmed cases and more than 285,000 deaths, COVID-19 pandemic continues to harm significant number of people worldwide. Several studies have reported the impact of COVID-19 in general population; however, there is scarcity of information related to pharmacological management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and immunological response during pregnancy makes it more susceptible to infections. Furthermore, during pregnancy, a woman undergoes multiple interactions with the health care system that increases her chance of getting infected; therefore, managing pregnant population presents a unique challenge. This systematic review seeks to answer the following questions in relation to COVID-19: What are the different clinical characteristics presented in maternal and perinatal population? What are the different maternal and perinatal outcome measures reported? What are the distinct therapeutic interventions reported to treat COVID-19? Is it safe to use "medications" used in the treatment of COVID-19 during antenatal, perinatal, postnatal, and breastfeeding? The search will follow a comprehensive, sequential three step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including Medline, CINAHL, and LitCovid will be searched from the inception of the disease until the completion of data collection. The quality of this search strategy will be assessed using Peer Review of Electronic Search Strategies Evidence-Based Checklist (PRESS EBC). An eligibility form will be developed for a transparent screening and inclusion/exclusion of studies. All studies will be sent to RefWorks, and abstraction will be independently performed by two researchers. Risk of bias will be assessed using Cochrane Risk of Bias tool for randomized controlled trials, Newcastle-Ottawa Quality Assessment Scale for non-randomized studies, and for case reports, Murad et al. tool will be used. Decision to conduct meta-analysis will be based on several factors including homogeneity and outcome measures reported; otherwise, a narrative synthesis will be deemed appropriate. This systematic review will summarize the existing data on effect of COVID-19 on maternal and perinatal population. Furthermore, to the best of our knowledge, this is the first systematic review addressing therapeutic management and safety of medicines to treat COVID-19 during pregnancy and breastfeeding. This systematic review has been registered and published with Prospero ( CRD42020172773 ).
    Keywords COVID-19 ; Maternal ; Perinatal ; Pharmacological management ; Pregnant ; covid19
    Subject code 610
    Language English
    Publishing date 2020-07-18
    Publisher BMC
    Publishing country qa
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  6. Article ; Online: Maternal and perinatal outcomes and pharmacological management of Covid-19 infection in pregnancy

    Binny Thomas / Abdulrouf Pallivalapila / Wessam El Kassem / Asma Tarannum / Fatema Al Hail / Mohammed Rijims / Hussain Parappil / Arabo Ibrahim Bayo / Shamsa Ahmad / Zachariah Nazar / Derek Stewart / Moza Al Hail

    Systematic Reviews, Vol 9, Iss 1, Pp 1-

    a systematic review protocol

    2020  Volume 7

    Abstract: ... management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and ... step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including ... This systematic review seeks to answer the following questions in relation to COVID-19: What are the different ...

    Abstract Abstract Background Over 4.2 million confirmed cases and more than 285,000 deaths, COVID-19 pandemic continues to harm significant number of people worldwide. Several studies have reported the impact of COVID-19 in general population; however, there is scarcity of information related to pharmacological management and maternal and perinatal outcomes during the pandemic. Altered physiological, anatomical, and immunological response during pregnancy makes it more susceptible to infections. Furthermore, during pregnancy, a woman undergoes multiple interactions with the health care system that increases her chance of getting infected; therefore, managing pregnant population presents a unique challenge. Research questions This systematic review seeks to answer the following questions in relation to COVID-19: What are the different clinical characteristics presented in maternal and perinatal population? What are the different maternal and perinatal outcome measures reported? What are the distinct therapeutic interventions reported to treat COVID-19? Is it safe to use “medications” used in the treatment of COVID-19 during antenatal, perinatal, postnatal, and breastfeeding? Method The search will follow a comprehensive, sequential three step search strategy. Several databases relevant to COVID-19 and its impact on pregnancy including Medline, CINAHL, and LitCovid will be searched from the inception of the disease until the completion of data collection. The quality of this search strategy will be assessed using Peer Review of Electronic Search Strategies Evidence-Based Checklist (PRESS EBC). An eligibility form will be developed for a transparent screening and inclusion/exclusion of studies. All studies will be sent to RefWorks, and abstraction will be independently performed by two researchers. Risk of bias will be assessed using Cochrane Risk of Bias tool for randomized controlled trials, Newcastle–Ottawa Quality Assessment Scale for non-randomized studies, and for case reports, Murad et al. tool will be used. Decision ...
    Keywords COVID-19 ; Maternal ; Perinatal ; Pharmacological management ; Pregnant ; Medicine ; R
    Subject code 306 ; 610
    Language English
    Publishing date 2020-07-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top